KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universal Health Services (UHS) Gains from Sales and Divestitures (2016 - 2025)

Universal Health Services' Gains from Sales and Divestitures history spans 17 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures fell 34.67% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, down 34.67%, while the annual FY2025 figure was $1.2 million, 34.67% down from the prior year.
  • Gains from Sales and Divestitures reached $1.2 million in Q4 2025 per UHS's latest filing, down from $1.8 million in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $2.2 million in Q4 2021 to a low of $1.2 million in Q4 2025.
  • Average Gains from Sales and Divestitures over 5 years is $1.9 million, with a median of $2.0 million recorded in 2023.
  • Peak YoY movement for Gains from Sales and Divestitures: increased 1.54% in 2021, then crashed 34.67% in 2025.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $2.2 million in 2021, then decreased by 3.48% to $2.1 million in 2022, then decreased by 7.11% to $2.0 million in 2023, then fell by 10.33% to $1.8 million in 2024, then plummeted by 34.67% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for UHS's Gains from Sales and Divestitures are $1.2 million (Q4 2025), $1.8 million (Q4 2024), and $2.0 million (Q4 2023).